Literature DB >> 21989242

FSTL5--a new prognostic biomarker for medulloblastoma.

Katie Kingwell.   

Abstract

Entities:  

Year:  2011        PMID： 21989242     DOI： 10.1038/nrneurol.2011.156

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

Authors:  Marc Remke; Thomas Hielscher; Andrey Korshunov; Paul A Northcott; Sebastian Bender; Marcel Kool; Frank Westermann; Axel Benner; Huriye Cin; Marina Ryzhova; Dominik Sturm; Hendrik Witt; Daniel Haag; Grischa Toedt; Andrea Wittmann; Anna Schöttler; André O von Bueren; Andreas von Deimling; Stefan Rutkowski; Wolfram Scheurlen; Andreas E Kulozik; Michael D Taylor; Peter Lichter; Stefan M Pfister
Journal:  J Clin Oncol       Date:  2011-09-12       Impact factor: 44.544
  1 in total
  2 in total

1.  Next-generation sequencing identified SPATC1L as a possible candidate gene for both early-onset and age-related hearing loss.

Authors:  Anna Morgan; Dragana Vuckovic; Navaneethakrishnan Krishnamoorthy; Elisa Rubinato; Umberto Ambrosetti; Pierangela Castorina; Annamaria Franzè; Diego Vozzi; Martina La Bianca; Stefania Cappellani; Mariateresa Di Stazio; Paolo Gasparini; Giorgia Girotto
Journal:  Eur J Hum Genet       Date:  2018-09-03       Impact factor: 4.246

2.  Development of a Clinical and Genetic Prediction Model for Early Intestinal Resection in Patients with Crohn's Disease: Results from the IMPACT Study.

Authors:  Eun Ae Kang; Jongha Jang; Chang Hwan Choi; Sang Bum Kang; Ki Bae Bang; Tae Oh Kim; Geom Seog Seo; Jae Myung Cha; Jaeyoung Chun; Yunho Jung; Hyun Gun Kim; Jong Pil Im; Sangsoo Kim; Kwang Sung Ahn; Chang Kyun Lee; Hyo Jong Kim; Min Suk Kim; Dong Il Park
Journal:  J Clin Med       Date:  2021-02-07       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.